Sotera Health (SHC) Total Non-Current Liabilities (2020 - 2026)
Sotera Health (SHC) posted quarterly Total Non-Current Liabilities of $2.6 billion for Q1 2026, down 2.8% year-over-year from $2.6 billion in Q1 2025, and down 1.69% quarter-over-quarter from $2.6 billion in Q4 2025.
Sotera Health (SHC) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Sotera Health's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $2.6 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 2.8% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $2.6 billion (down 2.8% YoY), while the FY2025 annual figure was $2.6 billion, down 0.53% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $2.6 billion, down from $2.6 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $3.0 billion in Q1 2023, with the low at $2.2 billion in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $2.6 billion (2024), against an average of $2.6 billion.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities surged 38.22% in 2023, then slipped 14.2% in 2024.
- Sotera Health's Total Non-Current Liabilities stood at $2.7 billion in 2022, then declined by 3.06% to $2.6 billion in 2023, then slipped by 0.81% to $2.6 billion in 2024, then retreated by 0.53% to $2.6 billion in 2025, then slipped by 1.69% to $2.6 billion in 2026.
- Business Quant data shows SHC's Total Non-Current Liabilities at $2.6 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Sotera Health | 5.58 Bn | 5.22 Bn | 177.96 Mn | 2.59 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.59 Bn |
| Mar 31, 2026 | 2.56 Bn |
| Dec 31, 2025 | 2.60 Bn |
| Sep 30, 2025 | 2.58 Bn |
| Jun 30, 2025 | 2.65 Bn |
| Mar 31, 2025 | 2.63 Bn |
| Dec 31, 2024 | 2.62 Bn |
| Sep 30, 2024 | 2.63 Bn |
| Jun 30, 2024 | 2.59 Bn |
| Mar 31, 2024 | 2.58 Bn |
| Dec 31, 2023 | 2.64 Bn |
| Sep 30, 2023 | 2.61 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Mar 31, 2023 | 3.01 Bn |
| Dec 31, 2022 | 2.72 Bn |
| Sep 30, 2022 | 2.16 Bn |
| Jun 30, 2022 | 2.16 Bn |
| Mar 31, 2022 | 2.15 Bn |
| Dec 31, 2021 | 2.16 Bn |
| Sep 30, 2021 | 2.17 Bn |